Historically, such behavioral complexity was viewed as a disqualifying feature for drug development, as CNS-acting agents were associated with unpredictable neuropsychiatric liability and high regulatory barriers ( 5.4 Translational lessons from abandoned appetite peptides The historical trajectory of appetite and behavioral peptides reveals a recurring pattern: early development efforts often failed due to inadequate control over exposure, insufficient combination strategies, or overly conservative interpretations of side effects
While GLP-1 drugs are not cancer treatments, reducing this metabolic stress may have broader long-term implications
Weight-loss surgery effectively reduces weight and complications in patients with severe obesity
Once in Stockholm, Turner learnt about three new polypeptides recently isolated and purified by Mutt's team which they had partially characterised pharmacologically
These drugs calm the storm around weight loss
Healthcare providers typically review participant progress, body weight trends, and any side effects before making dose increases